Cancer
📧 Sign up to get email alerts when something new happens for Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-07-21Clinical Trial Update: Effect of Sipjeondaebo-tang for Cancer Related Anorexia in Cancer Patients [NA]
This update notes a completed clinical trial evaluating Sipjeondaebo-tang for cancer-related anorexia in cancer patients.
-
CLINICAL_TRIALS trial_result · 2017-07-17Clinical Trial Update: Mindfulness Based Stress Reduction: Supportive Treatment for Adult Patients With Cancer and Their Partners [NA]
The Mindfulness Based Stress Reduction trial for adult cancer patients and their partners has completed. The clinical trial status is finish…
-
CLINICAL_TRIALS research · 2017-07-14Clinical Trial Update: Implementation of a Return Home With a Hospitalization at Home or With a Home Health Care Provider From the Services of Oncopneumology, Oncology and Hematology of University Hospital of Strasbourg
This document reports a clinical trial update on implementing a return-home hospitalization model for cancer patients at the University Hosp…
-
EMA withdrawal · 2017-07-12EMA Withdrawn: Removab (catumaxomab) — Neovii Biotech GmbH
Removab (catumaxomab) has been withdrawn from the market by Neovii Biotech GmbH.
-
CLINICAL_TRIALS trial_result · 2017-07-12Clinical Trial Update: Phase I, Dose-escalation Trial of BAY1187982 in Subjects With Advanced Solid Tumors Known to Express Fibroblast Growth Factor Receptor 2 (FGFR2) [Phase 1]
A Phase I dose-escalation trial of BAY1187982 in FGFR2-expressing advanced solid tumors has been terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-07-11Clinical Trial Update: Open-label, Single Arm, Tumor Imaging and Dosimetry Study of I-124 PGN650 in Advanced Solid Tumors [EARLY_Phase 1]
An early-phase, open-label, single-arm imaging and dosimetry study of the radiolabeled agent I-124 PGN650 in patients with advanced solid tu…
-
CLINICAL_TRIALS withdrawal · 2017-07-11Clinical Trial Update: Effectiveness of Ketamine in Malignant Neuropathic Pain Relief [Phase 3]
A Phase 3 trial evaluating ketamine for malignant neuropathic pain has been withdrawn, with no results reported.
-
CLINICAL_TRIALS trial_result · 2017-07-06Clinical Trial Update: Tinzaparin for Primary Treatment and Extended Secondary Prophylaxis of Venous Thromboembolism in Patients With Cancer [Phase 2]
Phase 2 trial of tinzaparin for primary treatment and extended secondary prophylaxis of venous thromboembolism in cancer patients was termin…
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Effect of Tai Chi Vs. Structured Exercise on Physical Fitness and Stress in Cancer Survivors [Phase 2]
Phase 2 trial comparing Tai Chi to structured exercise in cancer survivors evaluated effects on physical fitness and stress; the study is sp…
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Phase I Study of HeFi-1 to Treat Cancers With CD30 Protein [Phase 1]
A Phase I trial of HeFi-1 for cancers expressing CD34? expressing CD30? Wait: The document states CD30 proteins; the summary is updated here…
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: SNX-5422 to Treat Solid Tumor Cancers and Lymphomas [Phase 1]
Phase 1 trial results for SNX-5422 in solid tumors and lymphomas have completed.
-
CLINICAL_TRIALS research · 2017-07-02Clinical Trial Update: Communicating a Cancer Diagnosis-Current Methods and Their Effects
This completed clinical trial examines current methods of communicating a cancer diagnosis and their effects on patients.
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: A Pilot Trial of Oral Topotecan for the Treatment of Refractory Advanced Solid Neoplasms Expressing HIF-1a [Phase 1]
This Phase 1 pilot trial evaluated the safety, tolerability, and preliminary activity of oral topotecan in patients with refractory advanced…
-
CLINICAL_TRIALS withdrawal · 2017-07-02Clinical Trial Update: ABT-888, Carboplatin, and Paclitaxel for Cancer With Liver or Kidney Problems [Phase 1]
Phase 1 trial of ABT-888 (veliparib) with carboplatin and paclitaxel for cancer patients with liver or kidney impairment has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Characterization of the Pharmacokinetics of Oral Selenium Compounds in Humans Before and Following Supplementation
A completed clinical trial characterizes the pharmacokinetics of oral selenium compounds in humans before and after supplementation.
-
CLINICAL_TRIALS research · 2017-07-02Clinical Trial Update: Views of Cancer Patients Regarding Financial Conflicts of Interest
A completed NIH Clinical Center study surveyed cancer patients to understand their views on financial conflicts of interest in cancer resear…
-
CLINICAL_TRIALS research · 2017-07-02Clinical Trial Update: Family Health Study (Validation of a Family History of Cancer Questionnaire for Risk Factor Surveillance)
Completed clinical trial validating a questionnaire on family history of cancer for use in risk factor surveillance.
-
CLINICAL_TRIALS trial_result · 2017-06-29Clinical Trial Update: Comparison of Prophylactic Antiviral Efficacy in Patients Undergoing Chemotherapy: Entecavir Versus Lamivudine [Phase 3]
A completed Phase 3 trial comparing entecavir to lamivudine for antiviral prophylaxis in patients undergoing chemotherapy. The study include…
-
CLINICAL_TRIALS trial_result · 2017-06-28Clinical Trial Update: Use of Propranolol to Reduce FDG Uptake in Brown Adipose Tissue in Pediatric Cancer Patients PET Scans
A completed pediatric cancer trial evaluated the use of propranolol to reduce FDG uptake in brown adipose tissue during PET scans, potential…
-
CLINICAL_TRIALS research · 2017-06-28Clinical Trial Update: Translation, Cross-cultural Adaptation and Validation of PRO-CTCAE for Italian-speaking Cancer Patients
This clinical trial update reports translation, cross-cultural adaptation, and validation of the PRO-CTCAE patient-reported outcome instrume…
-
CLINICAL_TRIALS trial_result · 2017-06-26Clinical Trial Update: Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-012/KEYNOTE-012) [Phase 1]
Phase 1 study of pembrolizumab (MK-3475) in advanced solid tumors has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2017-06-23Clinical Trial Update: Dose Escalation Study of Gemcitabine and ON 01910.Na in Solid Tumors [Phase 1]
Completed Phase 1 dose-escalation trial evaluating the combination of gemcitabine and ON-01910.Na in patients with solid tumors.
-
CLINICAL_TRIALS trial_result · 2017-06-23Clinical Trial Update: Safety Study of ON 01910.Na in Combination With Irinotecan or Oxaliplatin [Phase 1]
Phase 1 safety study of ON 01910.Na in combination with irinotecan or oxaliplatin for advanced solid tumors has completed.
-
CLINICAL_TRIALS trial_result · 2017-06-23Clinical Trial Update: Safety of ON 01910.Na as a 3-day Infusion in Patients With Advanced Cancer [Phase 1]
A Phase 1 trial evaluating the safety of ON 01910.Na given as a 3-day infusion in patients with advanced cancer has completed; the document …
-
CLINICAL_TRIALS trial_result · 2017-06-22Clinical Trial Update: Effectiveness of Nutritional Counselling and "Improved Atta" Supplementation in Cachexic Adult Indian Cancer Patients [NA]
A completed clinical trial in Indian cancer patients assessed the effectiveness of nutritional counselling combined with the 'Improved Atta'…